Emergent BioSolutions (EBS) Misses Q4 EPS by 16c
Tweet
Share
E-mailGet Alerts EBS Hot Sheet
Price: $7.26 -3.2%
EPS Growth %: -31.3%
Financial Fact:
Earnings per share - basic: 0.52
Today's EPS Names:
ORPB, ONEG, NDLS, More
EPS Growth %: -31.3%
Financial Fact:
Earnings per share - basic: 0.52
Today's EPS Names:
ORPB, ONEG, NDLS, More
Join SI Premium – FREE
Emergent BioSolutions (NYSE: EBS) reported Q4 EPS of $1.57, $0.16 worse than the analyst estimate of $1.73. Revenue for the quarter came in at $360.4 million versus the consensus estimate of $357.41 million.
For earnings history and earnings-related data on Emergent BioSolutions (EBS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Elon Musk’s trillion-dollar meltdown: How SpaceX and Tesla erased $700 billion
- Gentex Corporation (GNTX) Tops Q2 EPS by 8c ; Offers Guidance
- Choiceone Financial Services, Inc. (COFS) Misses Q2 EPS by 5c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
